591 related articles for article (PubMed ID: 30315100)
1. ER stress is not elevated in the 5XFAD mouse model of Alzheimer's disease.
Sadleir KR; Popovic J; Vassar R
J Biol Chem; 2018 Nov; 293(48):18434-18443. PubMed ID: 30315100
[TBL] [Abstract][Full Text] [Related]
2. Effects of BACE1 haploinsufficiency on APP processing and Aβ concentrations in male and female 5XFAD Alzheimer mice at different disease stages.
Devi L; Ohno M
Neuroscience; 2015 Oct; 307():128-37. PubMed ID: 26314636
[TBL] [Abstract][Full Text] [Related]
3. Genetic inhibition of phosphorylation of the translation initiation factor eIF2α does not block Aβ-dependent elevation of BACE1 and APP levels or reduce amyloid pathology in a mouse model of Alzheimer's disease.
Sadleir KR; Eimer WA; Kaufman RJ; Osten P; Vassar R
PLoS One; 2014; 9(7):e101643. PubMed ID: 24992504
[TBL] [Abstract][Full Text] [Related]
4. Treadmill exercise decreases β-amyloid burden in APP/PS1 transgenic mice involving regulation of the unfolded protein response.
Xia J; Li B; Yin L; Zhao N; Yan Q; Xu B
Neurosci Lett; 2019 Jun; 703():125-131. PubMed ID: 30905823
[TBL] [Abstract][Full Text] [Related]
5. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice.
Devi L; Ohno M
Eur J Neurosci; 2010 Jan; 31(1):110-8. PubMed ID: 20092558
[TBL] [Abstract][Full Text] [Related]
6. Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level.
Sadleir KR; Eimer WA; Cole SL; Vassar R
Mol Neurodegener; 2015 Jan; 10():1. PubMed ID: 25567526
[TBL] [Abstract][Full Text] [Related]
7. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
Paouri E; Tzara O; Zenelak S; Georgopoulos S
J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
[TBL] [Abstract][Full Text] [Related]
8. BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice.
Kim W; Ma L; Lomoio S; Willen R; Lombardo S; Dong J; Haydon PG; Tesco G
Mol Neurodegener; 2018 Feb; 13(1):6. PubMed ID: 29391027
[TBL] [Abstract][Full Text] [Related]
9. Gallic acid is a dual α/β-secretase modulator that reverses cognitive impairment and remediates pathology in Alzheimer mice.
Mori T; Koyama N; Yokoo T; Segawa T; Maeda M; Sawmiller D; Tan J; Town T
J Biol Chem; 2020 Nov; 295(48):16251-16266. PubMed ID: 32913125
[TBL] [Abstract][Full Text] [Related]
10. PS1 Affects the Pathology of Alzheimer's Disease by Regulating BACE1 Distribution in the ER and BACE1 Maturation in the Golgi Apparatus.
Li N; Qiu Y; Wang H; Zhao J; Qing H
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555791
[TBL] [Abstract][Full Text] [Related]
11. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice.
Devi L; Ohno M
Mol Brain; 2015 Mar; 8():19. PubMed ID: 25884928
[TBL] [Abstract][Full Text] [Related]
12. Phospho-eIF2α level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice.
Devi L; Ohno M
PLoS One; 2010 Sep; 5(9):e12974. PubMed ID: 20886088
[TBL] [Abstract][Full Text] [Related]
13. Ca
Yu Z; Dou F; Wang Y; Hou L; Chen H
J Neuroinflammation; 2018 Nov; 15(1):316. PubMed ID: 30442153
[TBL] [Abstract][Full Text] [Related]
14. Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease.
Sadleir KR; Kandalepas PC; Buggia-Prévot V; Nicholson DA; Thinakaran G; Vassar R
Acta Neuropathol; 2016 Aug; 132(2):235-256. PubMed ID: 26993139
[TBL] [Abstract][Full Text] [Related]
15. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
Cai Z; Wang C; He W; Chen Y
Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
[TBL] [Abstract][Full Text] [Related]
16. 1950 MHz Electromagnetic Fields Ameliorate Aβ Pathology in Alzheimer's Disease Mice.
Jeong YJ; Kang GY; Kwon JH; Choi HD; Pack JK; Kim N; Lee YS; Lee HJ
Curr Alzheimer Res; 2015; 12(5):481-92. PubMed ID: 26017559
[TBL] [Abstract][Full Text] [Related]
17. Calpain activation promotes BACE1 expression, amyloid precursor protein processing, and amyloid plaque formation in a transgenic mouse model of Alzheimer disease.
Liang B; Duan BY; Zhou XP; Gong JX; Luo ZG
J Biol Chem; 2010 Sep; 285(36):27737-44. PubMed ID: 20595388
[TBL] [Abstract][Full Text] [Related]
18. Disrupted Maturation of Prefrontal Layer 5 Neuronal Circuits in an Alzheimer's Mouse Model of Amyloid Deposition.
Chen C; Wei J; Ma X; Xia B; Shakir N; Zhang JK; Zhang L; Cui Y; Ferguson D; Qiu S; Bai F
Neurosci Bull; 2023 Jun; 39(6):881-892. PubMed ID: 36152121
[TBL] [Abstract][Full Text] [Related]
19. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor
Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G
J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199
[TBL] [Abstract][Full Text] [Related]
20. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
